METASTATIC HER2 NEGATIVE BREAST CARCINOMA
Clinical trials for METASTATIC HER2 NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HER2 NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC HER2 NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive drug combo shows promise against bone metastases in breast cancer trial
Disease control OngoingThis study tests whether adding a radioactive drug (radium-223) to standard chemotherapy (paclitaxel) helps people with advanced breast cancer that has spread to their bones. The radioactive drug targets bone tumors specifically, while chemo works throughout the body. About 70 pa…
Matched conditions: METASTATIC HER2 NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:15 UTC
-
New drug cocktail shows promise for Hard-to-Treat breast cancer
Disease control OngoingThis study tests whether adding a drug called copanlisib to the usual two-drug therapy (fulvestrant and abemaciclib) works better for people with a certain type of advanced breast cancer (hormone receptor-positive, HER2-negative) that has spread. The trial involves 24 participant…
Matched conditions: METASTATIC HER2 NEGATIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
New drug combo targets breast cancer in the brain
Disease control OngoingThis study tests a drug called sacituzumab govitecan in 44 people with HER2-negative breast cancer that has spread to the brain. The drug works like a smart bomb, attaching to a protein on cancer cells and delivering chemotherapy directly to them. The goal is to see if it can shr…
Matched conditions: METASTATIC HER2 NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 26, 2026 04:37 UTC